Predrag Sikirics group (School of Medicine, University of Zagreb, 1991 ) Most common experimental dose in animal studies: 10 g/kg intraperitoneally or per os, daily Standard targeted pathways: VEGFR2 angiogenesis, NO synthase , 5-HT2A serotonin receptor, dopamine D2 receptor Clinical program in Croatia halted at Phase 2 (Crohns disease) WADA Prohibited List: added in 2022 to category S0 (Non-Approved Substances) Reference sources (PubMed) Sikiric P
Deficiency causes megaloblastic anemia abnormally large, dysfunctional red cells that impair oxygen delivery, producing fatigue, shortness of breath, and pallor
Coverage applies only to FDA-approved type 2 diabetes treatment with documentation and prior authorization
They require no preparation and can be consumed in small amounts , which fits well with reduced appetite and changing routines
Johns wort across more than 3,800 participants in 27 clinical trials (Ng et al., 2017), supporting the notion that at least in part, inhibition of PKC plays a role in the effect of St